Login Register Cart 0
Generic placeholder image

Current Drug Metabolism

Editor-in-Chief

ISSN (Print): 1389-2002
ISSN (Online): 1875-5453

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Trends in Rationalized Brain Targeted Nanoparticles in Neurological Disorders (Part-III)

Author(s): Md. Noushad Javed, Ghulam Md. Ashraf, George E. Barreto and Mohd. Javed Naim

Volume 22, Issue 4, 2021

Page: [250 - 250] Pages: 1

DOI: 10.2174/138920022204210517114829

« Previous Next »
[1]
Pottoo, F.H.; Tabassum, N.; Javed, M.N.; Nigar, S.; Sharma, S.; Barkat, M.A. Harshita; Alam, M.S.; Ansari, M.A.; Barreto, G.E.; Ashraf, G.M. Raloxifene potentiates the effect of fluoxetine against maximal electroshock induced seizures in mice. Eur. J. Pharm. Sci., 2020, 146105261
[http://dx.doi.org/10.1016/j.ejps.2020.105261] [PMID: 32061655]
[2]
Pottoo, F.H.; Sharma, S.; Javed, M.N.; Barkat, M.A. Harshita, Alam, M.S.; Naim, M.J.; Alam, O.; Ansari, M.A.; Barreto, G.E.; Ashraf, G.M. Lipid-based nanoformulations in the treatment of neurological disorders. Drug Metab. Rev., 2020, 52(1), 185-204.
[http://dx.doi.org/10.1080/03602532.2020.1726942] [PMID: 32116044]
[3]
Raman, S.; Mahmood, S.; Hilles, A.R.; Javed, M.N.; Azmana, M.; Al-Japairai, K.A.S. Polymeric nanoparticles for brain drug delivery - a review. Curr. Drug Metab., 2020, 21(9), 649-660.
[http://dx.doi.org/10.2174/1389200221666200508074348] [PMID: 32384025]
[4]
Harakeh, S.; Qari, M.H.; Ramadan, W.S.; Al Jaouni, S.K.; Al Muhayawi, M.S.; Al Amri, T.; Md Ashraf, G.; Bharali, D.J.; Mousa, S.A. Novel nano-formulations of ellagic acid are promising in restoring oxidative homeostasis in rat brains with Alzheimer’s disease. Curr. Drug Metab., 2020, 22(4), 299-307.
[http://dx.doi.org/10.2174/1389200221666201216170851] [PMID: 33327909]
[5]
Sharma, S.; Rabbani, S.A.; Agarwal, T.; Baboota, S.; Pottoo, F.H.; Kadian, R. Nanotechnology driven approaches for the management of Parkinson’s disease: current status and future perspectives. Curr. Drug Metab., 2020, 22(4), 287-298.
[http://dx.doi.org/10.2174/1389200221666201124123405] [PMID: 33234098]
[6]
Sharma, A.; Manchanda, R.; Pottoo, F.H.; Ashraf, G.M. Nano-neurotherapeutics (NNTs): an emergent and multifaceted tool for CNS disorders. Curr. Drug Metab., 2020, 22(4), 251-262.
[http://dx.doi.org/10.2174/1389200221666201124123939] [PMID: 33234099]
[7]
Nabi, B.; Rehman, S.; Pottoo, F.H.; Baboota, S.; Ali, J. Directing the antiretroviral drugs to the brain reservoir: a nanoformulation approach for NeuroAIDS. Curr. Drug Metab., 2020, 22(4), 280-286.
[http://dx.doi.org/10.2174/1389200221666200923151036] [PMID: 32964821]
[8]
Muheem, A.; Jahangir, M.A.; Jaiswal, C.P.; Jafar, M.; Ahmad, M.Z.; Ahmad, J.; Warsi, M.H. Recent patents, regulatory issues, and toxicity of nanoparticles in neuronal disorders. Curr. Drug Metab., 2020, 22(4), 263-279.
[http://dx.doi.org/10.2174/1389200221999201210213036] [PMID: 33305703]

Rights & Permissions Print Cite
Article Metrics
15
1
© 2024 Bentham Science Publishers | Privacy Policy